One of the most popular ADHD drugs may cause hallucinations and other psychotic symptoms
(Exeley Inc.) One of the most popular ADHD drugs may cause hallucinations and other psychotic symptoms. Research published in the SJCAPP says that possible adverse symptoms may affect 1.1 percent -- 2.5 percent of ADHD patients treated with methylphenidate. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 22, 2018 Category: International Medicine & Public Health Source Type: news

Jornay PM (Methylphenidate Hydrochloride Extended-release Capsules ) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 17, 2018 Category: Drugs & Pharmacology Source Type: news

Methylphenidate Good First - Choice Pediatric ADHD Drug
For adults, amphetamines are reasonable first choice to treat attention - deficit hyperactivity disorder (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - August 17, 2018 Category: Psychiatry Tags: Family Medicine, Internal Medicine, Neurology, Nursing, Pediatrics, Pharmacy, Psychiatry, Journal, Source Type: news

Methylphenidate Good First-Choice Pediatric ADHD Drug
THURSDAY, Aug. 16, 2018 -- Methylphenidate should be considered as a first choice for the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents, while amphetamines should be considered as a first choice in adults,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 16, 2018 Category: Pharmaceuticals Source Type: news

FDA Clears First ADHD Bedtime Medication FDA Clears First ADHD Bedtime Medication
Jornay PM is a novel formulation of methylphenidate taken in the evening instead of first thing in the morning to provide early-morning control of attention-deficit/hyperactivity disorder (ADHD) symptoms.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 10, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Methylphenidate Best First-Line Drug Choice for ADHD in Kids Methylphenidate Best First-Line Drug Choice for ADHD in Kids
Methylphenidate appears to be the best first-line drug choice for attention- deficit/hyperactivity disorder (ADHD) in children and adolescents, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 10, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news

FDA Approves Jornay PM (methylphenidate) Extended-Release Capsules for Attention Deficit Hyperactivity Disorder (ADHD)
GEORGE TOWN, Cayman Islands--(BUSINESS WIRE)August 09, 2018 --Ironshore Pharmaceuticals& Development, Inc. ( “Ironshore”) a wholly owned subsidiary of Highland Therapeutics Inc. (“Highland”) announced today that the U.S. Food and Drug... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 9, 2018 Category: Drugs & Pharmacology Source Type: news

Which Drugs Work Best for ADHD? Large Study Zeroes in on Two
The researchers compared seven ADHD drugs -- amphetamines (including lisdexamfetamine), atomoxetine, bupropion, clonidine, guanfacine, methylphenidate and modafinil -- and a placebo over 12 weeks of treatment. (Source: WebMD Health)
Source: WebMD Health - August 8, 2018 Category: Consumer Health News Source Type: news

ADHD experts say more children with condition should be given drugs
An NHS-funded study has found that Ritalin is still the best medical option for children with ADHD – reducing symptoms by 78 per cent. Only 0.5 per cent of under-16s in the UK receive the drugs currently. (Source: the Mail online | Health)
Source: the Mail online | Health - August 8, 2018 Category: Consumer Health News Source Type: news

Which Drugs Work Best for ADHD? Large Study Zeroes in on Two
WEDNESDAY, Aug. 8, 2018 -- Researchers have identified what they describe as the safest, most effective short-term drug treatments for attention deficit/hyperactivity disorder (ADHD). It's methylphenidate for kids and amphetamines for adults,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 8, 2018 Category: General Medicine Source Type: news

Ritalin-type drugs best to treat ADHD in children, shows study
Methylphenidate drugs safest and most effective while adults do better on amphetaminesRitalin and other drugs of the same class are the most effective and safest medications to prescribe for children with attention deficit hyperactivity disorder (ADHD), according to a major scientific review.The review of ADHD drugs shows that they work, and work well, in spite of concerns among the public and some doctors that children in the UK are being overmedicated. Ofsted ’s chief inspector, Amanda Spielman, has likened the drugs to a “chemical cosh” and claimed they were being overprescribed, disguising bad behavio...
Source: Guardian Unlimited Science - August 8, 2018 Category: Science Authors: Sarah Boseley Health editor Tags: Attention deficit hyperactivity disorder Mental health UK news Source Type: news

ADHD experts say more children with condition should be given drugs as only one in ten currently are
An NHS-funded study has found that Ritalin is still the best medical option for children with ADHD – reducing symptoms by 78 per cent. Only 0.5 per cent of under-16s in the UK receive the drugs currently. (Source: the Mail online | Health)
Source: the Mail online | Health - August 8, 2018 Category: Consumer Health News Source Type: news

Methylphenidate best drug for hyperactive kids in short-term
But consider non-drug options first, concludes pooled analysis of data from 133 trials Related items fromOnMedica Monthly testing with isotretinoin might be unnecessary CBT helps children to kick obsessions Lorazepam no better than diazepam for child seizures Broader definition of ADHD raises risk of needless treatment One in 10 children in phase I cancer trials respond to drugs (Source: OnMedica Latest News)
Source: OnMedica Latest News - August 8, 2018 Category: UK Health Source Type: news

Meds not the only answer for ADHD | Letters
There need to be national multi-agency collaborative pathways for the holistic assessment of children with attention difficultiesWe, as chartered psychologists (BPS), are delighted that the inadequate provision for children with mental health difficulties in the UK was highlighted (Shocking failures on children with ADHD, 4 August). We agree with the findings that there are considerable local differences in practice in this field. We note with concern the reported rise in prescriptions for stimulant drugs such as Ritalin (methylphenidate) between 2010 and 2015. We should not fall into the trap of believing that diagnosis a...
Source: Guardian Unlimited Science - August 6, 2018 Category: Science Authors: Letters Tags: Attention deficit hyperactivity disorder Society Health Mental health NHS Conservatives Politics Psychology Science Source Type: news

UB research suggests how stimulant treatments for ADHD work
(University at Buffalo) Stimulant medications are an effective treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). In the classroom, parents and teachers say that medications like methylphenidate (MPH) can reduce symptoms and improve behavior.Although stimulants have been in use for decades to treat ADHD in school-aged children, just how they work hasn't been clear. But the results of a new study in The Journal of Child Psychology and Psychiatry is filling in critical gaps about the role of improved cognitive functions. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 27, 2018 Category: International Medicine & Public Health Source Type: news

ADHD Medications Unlikely To Improve School Performance In Kids Without ADHD
BOSTON (CBS) — Many college students who don’t have ADHD illegally use ADHD medications, like Adderall and Ritalin, to try to boost their performance in school. But is that a smart way to go? Probably not, according to a new study from the University of Rhode Island and Brown University. Researchers looked at 13 undergrads and found that Adderall did improve attention and focus but that did not result in better performance of tests. The drug also appeared to impair working memory. This was a very small study so more research is needed, but in the meantime, students who don’t have ADHD should be discourage...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 23, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Seen On WBZ-TV Syndicated Local Uncategorized ADHD Dr. Mallika Marshall Local TV Source Type: news

Use of Ritalin and other 'smart drugs' doubled in last decade in UK
Head of Ofsted Amanda Spielman said the figures were worrying and warned parents against using quick fix drugs. There were 1.5 million prescriptions in the last year in Britain by the NHS. (Source: the Mail online | Health)
Source: the Mail online | Health - June 26, 2018 Category: Consumer Health News Source Type: news

Use of Ritalin and other 'smart drugs' has DOUBLED in last decade in Britain
Head of Ofsted Amanda Spielman said the figures were worrying and warned parents against using quick fix drugs. There were 1.5 million prescriptions in the last year in Britain by the NHS. (Source: the Mail online | Health)
Source: the Mail online | Health - June 26, 2018 Category: Consumer Health News Source Type: news

Methylphenidate Hydrochloride (QUILLIVANT XR) for Extended-Release Oral Suspension (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 22, 2018 Category: Drugs & Pharmacology Source Type: news

NRA's incoming president ties Ritalin to school shootings
Oliver North, the National Rifle Association's incoming president, suggested on "Fox News Sunday" that Ritalin -- a drug commonly used to treat ADHD -- is somehow linked with school shootings. Experts weigh in on that idea. (Source: CNN.com - Health)
Source: CNN.com - Health - May 21, 2018 Category: Consumer Health News Source Type: news

Ritalin does NOT turn kids into killers, doctors say after the NRA blamed ADHD drugs for shootings   
Doctors are hitting back to refute claims from incoming NRA president Lt Col Oliver North's claims that ADHD medications like Ritalin could drive students to violence like Friday's school shooting. (Source: the Mail online | Health)
Source: the Mail online | Health - May 21, 2018 Category: Consumer Health News Source Type: news

NRA links school violence to Ritalin but experts deny connection
If anything, experts say, children on the medication tend to be less aggressive (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 21, 2018 Category: Consumer Health News Source Type: news

Huge surge in kids poisoned by ADHD pills since 2000
Between 2000 and 2014, around 10,000 American children under 19 were hospitalized, and three died after taking methylphenidate or amphetamine, a new study reveals. (Source: the Mail online | Health)
Source: the Mail online | Health - May 21, 2018 Category: Consumer Health News Source Type: news

Unnecessary And Accidental Use Of ADHD Drugs Increases Over 60%, Study Suggests
(CNN) — Exposure to common medications used to treat attention deficit hyperactivity disorder has increased by more than 60% in US children and adolescents, according to a new study. The study, published Monday in the journal Pediatrics, looked at all calls to US poison control centers for unintentional or intentional exposure to ADHD medications between 2000 and 2014 among children and adolescents. The researchers found that the number of calls increased from 7,018 in 2000 to 11,486 in 2014 — a 64% increase. According to the study’s authors, “exposure” refers to the unnecessary ingestion, inh...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 21, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health ADHD Local TV Source Type: news

What Causes Flushing?
Discussion Flushing is usually thought of as a benign condition such as blushing, but can be quite irritating if it is frequent or persistent (i.e. menopausal hot flashes) or even pathologic (i.e. malignancy). “Flushing is a subjective and sensation of warmth that is accompanied by reddening of the skin anywhere on the body but favors the face, neck, and upper torso…. Flushing can be broadly divided into episodic or persistent. Episodic flashing is mediated by the release of endogenous vasoactive mediators or medications, while persistent flushing result in a fixed facial erythema with telangiectasias and cyan...
Source: PediatricEducation.org - April 30, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

April 2018 RxNorm Release Available for Download
The RxNorm April 2018 Release is now available for download. A new Qualitative Distinction (QD) modifier “BX Rating” is included to distinguish generic methylphenidate products not therapeutically equivalent to the brand-name drug Concerta. (Source: UMLS News)
Source: UMLS News - April 13, 2018 Category: Databases & Libraries Source Type: news

Experts Warn of Emerging ‘Stimulant Epidemic’
Abuse of stimulants like methamphetamine, cocaine and even prescription drugs like Adderall and Ritalin is surging across the country, fed by cheap, potent and plentiful supplies. (Source: WebMD Health)
Source: WebMD Health - April 3, 2018 Category: Consumer Health News Source Type: news

Here are some biotech song requests for Diana Ross at the 2018 BIO convention
This June, some 16,000 people will descend on the Boston Convention& Exhibition Center for the BIO International Convention, a closely-watched annual gathering that gives biotech companies another platform to pitch themselves to investors and each other. And they’ll be joined by a special guest: Diana Ross. The Biotechnology Innovation Organization, the lobbying group that organizes the event, announced on Wednesday that the Motown star and former lead singer of The Supremes will perform a concert… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 15, 2018 Category: American Health Authors: Max Stendahl Source Type: news

Study points to potential misuse/abuse of ADHD drugs
(Wiley) A new British Journal of Clinical Pharmacology study indicates that methylphenidate, a central nervous system stimulant approved to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy, may be subject to misuse and/or abuse. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 7, 2018 Category: International Medicine & Public Health Source Type: news

Methylphenidate Hydrochloride (QUILLICHEW ER) Extended-Release Chewable Tablets (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - February 14, 2018 Category: Drugs & Pharmacology Source Type: news

Amneal Launches Methylphenidate Hydrochloride Extended-Release Tablets, USP (CII) AB-Rated Generic for Concerta(R)
BRIDGEWATER, N.J., Feb. 5, 2018 -- (Healthcare Sales & Marketing Network) -- Amneal Pharmaceuticals has launched methylphenidate hydrochloride extended-release tablets, USP (CII) in 18, 27, 36, and 54 mg strengths. Amneal's methylphenidate is an AB-rat... Biopharmaceuticals, Generics, Product Launch Amneal Pharmaceuticals, methylphenidate, Concerta (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 5, 2018 Category: Pharmaceuticals Source Type: news

Cotempla XR ODT (Methylphenidate Extended-Release Orally Disintegrating Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 31, 2018 Category: Drugs & Pharmacology Source Type: news

Methylphenidate Hydrochloride (QUILLICHEW ER) Extended-Release Chewable Tablets (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - January 22, 2018 Category: Drugs & Pharmacology Source Type: news

Methylphenidate Hydrochloride (QUILLIVANT XR) for Extended-Release Oral Suspension (New - Currently in Shortage
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - January 22, 2018 Category: Drugs & Pharmacology Source Type: news

Young Women Are Using A.D.H.D. Drugs in Greater Numbers, C.D.C. Reports
Since 2003, the percentage of women filling prescriptions for drugs like Ritalin has increased nearly fivefold in some age groups. (Source: NYT Health)
Source: NYT Health - January 18, 2018 Category: Consumer Health News Authors: BENEDICT CAREY Tags: Attention Deficit Hyperactivity Disorder Women and Girls Drugs (Pharmaceuticals) Pregnancy and Childbirth Centers for Disease Control and Prevention Source Type: news

ADHD drug tied to heart defects in babies
(Reuters Health) - - Pregnant women who take drugs like Ritalin and Concerta for attention deficit hyperactivity disorder (ADHD) are more likely than those who don ’t to have babies with heart deformities and other birth defects, a recent study suggests. (Source: Reuters: Health)
Source: Reuters: Health - January 5, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Ritalin During Pregnancy May Raise Risk of Heart Defect in Baby
A new study found a small increased risk of having a baby with a heart defect if Ritalin/Concerta  (methylphenidate) was taken by the mother-to-be. (Source: WebMD Health)
Source: WebMD Health - December 13, 2017 Category: Consumer Health News Source Type: news

Ritalin During Pregnancy May Raise Risk of Heart Defect in Baby
Source: HealthDay Related MedlinePlus Pages: Attention Deficit Hyperactivity Disorder, Congenital Heart Defects, Pregnancy and Medicines (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 13, 2017 Category: Consumer Health News Source Type: news

ADHD drug use in pregnancy increases risk of heart defects, study finds
The attention-deficit hyperactivity disorder drug methylphenidate is associated with an increased risk of heart defects in infants whose mothers take the medication during pregnancy, according to a study published Wednesday in the journal JAMA Psychiatry. (Source: CNN.com - Health)
Source: CNN.com - Health - December 13, 2017 Category: Consumer Health News Source Type: news

ADHD medication could cause birth defects
Children exposed to ADHD drugs like Ritalin in the first trimester are more likely to have heart deformities, according to a new study by the Brigham and Women's Hospital. (Source: the Mail online | Health)
Source: the Mail online | Health - December 13, 2017 Category: Consumer Health News Source Type: news

ADHD Meds During Pregnancy Appear To Have Low Risk Of Birth Defects
Most ADHD medications appear to have no increased risk for birth defects except a very small increased risk for heart defects with methylphenidate use in the first trimester. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 13, 2017 Category: Pharmaceuticals Authors: Tara Haelle, Contributor Source Type: news

Ritalin During Pregnancy May Raise Risk of Heart Defect in Baby
WEDNESDAY, Dec. 13, 2017 -- If you take Ritalin or Concerta for attention-deficit/hyperactivity disorder (ADHD) and you plan to become pregnant, you might want to talk to your doctor about switching your medication first. A new study found a small... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 13, 2017 Category: General Medicine Source Type: news

Extended-Release Methylphenidate Oral Tablets Extended-Release Methylphenidate Oral Tablets
A newly approved extended-release formulation of methylphenidate may be another option for the management of ADHD in children.Pediatric Pharmacotherapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 5, 2017 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news

Suicide risk reduction in youths with attention-deficit/hyperactivity disorder prescribed methylphenidate: a Taiwan nationwide population-based cohort study - Liang SH, Yang YH, Kuo TY, Liao YT, Lin TC, Lee Y, McIntyre RS, Kelsen BA, Wang TN, Chen VC.
BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) youths have increased suicide risk. Nevertheless, the beneficial effects of methylphenidate (MPH) on suicide attempt have received relatively little attention. AIMS: To investigate the MPH usage a... (Source: SafetyLit)
Source: SafetyLit - November 13, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

‘Relative’ school age biases ADHD diagnosis
Study suggests over-diagnosis in youngest Related items fromOnMedica Doctors should exercise caution in prescribing Ritalin for ADHD Attention deficit hyperactivity disorder (ADHD) New treatment options for ADHD Unhealthy diet during pregnancy may be linked to ADHD UK drug treatment of ADHD in children may have peaked (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 10, 2017 Category: UK Health Source Type: news

Stimulant Cuts Apathy, Improves Cognition in Mild Alzheimer's Stimulant Cuts Apathy, Improves Cognition in Mild Alzheimer's
Improved cognition among older veterans with mild Alzheimer's disease taking methylphenidate was somewhat unexpected.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 3, 2017 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Jimmy Kimmel Thinks ‘Donald Trump Has More Flip-Flops Than a Jimmy Buffett Concert’ So He Made a Supercut
Following the death of the Graham-Cassidy bill — the latest Senate attempt to repeal Obamacare — Jimmy Kimmel took to the Live! stage to express his relief that the proposal wouldn’t pass. Senate Majority Leader Mitch McConnell announced Tuesday that the Senate would not vote on Graham-Cassidy in the wake of Senators Susan Collins and John McCain declaring their opposition to it. However, the latter’s decision drew some blowback from President Donald Trump, who tweeted in criticism of McCain reversing his position on Obamacare — a stance that Kimmel found hypocritical. “The President had...
Source: TIME.com: Top Science and Health Stories - September 27, 2017 Category: Consumer Health News Authors: Megan McCluskey Tags: Uncategorized Donald Trump Health Care Jimmy Kimmel jimmy kimmel live Late Night Television politics TV Source Type: news

Most alternative therapies for treating autism show, at best, inconclusive benefits
Dr. Shafali Jeste knows well the desperation of a parent seeking a cure for their child with autism spectrum disorder. As a clinician who both researches the causes of the disorder and treats children with autism, Jeste, UCLA associate professor of psychiatry, neurology and pediatrics and a lead investigator in the UCLA Center for Autism Research and Treatment, understands why many parents will try anything that sounds reasonable. A change to a gluten- and casein-free diet to reduce symptoms. Mega-vitamins for the same. Medical marijuana to calm. Melatonin to sleep. Omega-3 fatty acids for hyperactivity. Delaying or refusi...
Source: UCLA Newsroom: Health Sciences - September 26, 2017 Category: Universities & Medical Training Source Type: news

New delayed-release stimulant improves morning ADHD symptoms and all-day functioning
(Mary Ann Liebert, Inc./Genetic Engineering News) A phase 3 study of children ages 6-12 years with attention deficit/hyperactivity disorder (ADHD) has shown that a delayed-release, long-acting formulation of the stimulant methylphenidate, when taken in the evening, led to significant improvement in ADHD symptoms and functional impairment first thing the next morning, compared to a placebo. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 25, 2017 Category: International Medicine & Public Health Source Type: news

A naturalistic comparison of methylphenidate and risperidone monotherapy in drug-naive youth with attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder and aggression - Masi G, Manfredi A, Nieri G, Muratori P, Pfanner C, Milone A.
BACKGROUND/PURPOSE: Attention-deficit/hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD) are frequently co-occurring in youth, but data about the pharmacological management of this comorbidity are scarce, especially when impulsive aggres... (Source: SafetyLit)
Source: SafetyLit - August 25, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news